Meso-jejunal lymph node dissection has a survival benefit in patients with remnant gastric cancer

BACKGROUND: Clinical benefits of the meso-jejunal lymph node (MJLN) dissection in remnant gastric cancer (RGC) patients have not been fully established. Hence, in this retrospective study, we evaluated the survival benefit of MJLN dissection and prognostic significance of MJLN metastasis in RGC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Sung Eun, Choi, Min-Gew, Lee, Jun Ho, Sohn, Tae Sung, Bae, Jae Moon, An, Ji Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171691/
https://www.ncbi.nlm.nih.gov/pubmed/37163530
http://dx.doi.org/10.1371/journal.pone.0285554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171691/
https://www.ncbi.nlm.nih.gov/pubmed/37163530
http://dx.doi.org/10.1371/journal.pone.0285554

Ejemplares similares